Assay Development Doctors Molecular Biology 
Drug Discovery World
APRIL 3, 2023
DS: What motivated you and Dr David Bunka, CTO, to create Aptamer and did you imagine you would one day be operating on such a global scale? AT : We initially met at the University of Leeds, where David was a post-doctoral researcher studying aptamers, and I was completing my PhD.
Elrig
APRIL 29, 2024
My role involved generating and characterizing complex proteins critical for biological assay development, hit discovery, and structural biology. She is involved in the research and development of cellular assays across multiple research areas for live-cell analysis applications, including AI-based image analysis tools.
Expert insights. Personalized for you.
130 
Let's personalize your content